ginsenoside rh2 has been researched along with Angiogenesis, Pathologic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, L; Gao, K; Li, P; Li, Z; Liu, J; Liu, S; Qi, Y; Qi, Z; Shao, Z; Sun, Y | 1 |
| Ding, Y; Gao, Y; Yi, X; Zhou, J | 1 |
2 other study(ies) available for ginsenoside rh2 and Angiogenesis, Pathologic
| Article | Year |
|---|---|
Immunomodulatory Effects of (24R)-Pseudo-Ginsenoside HQ and (24S)-Pseudo-Ginsenoside HQ on Cyclophosphamide-Induced Immunosuppression and Their Anti-Tumor Effects Study.
Topics: Animals; Apoptosis; Carcinoma, Hepatocellular; Cell Proliferation; Cyclophosphamide; Ginsenosides; Humans; Immunity, Innate; Immunologic Factors; Mice; Neovascularization, Pathologic; Phagocytosis; Signal Transduction; Spleen; T-Lymphocytes | 2019 |
Ginsenoside Rh2 Suppresses Neovascularization in Xenograft Psoriasis Model.
Topics: Animals; Disease Models, Animal; Dose-Response Relationship, Drug; Drugs, Chinese Herbal; Gene Expression; Ginsenosides; Heterografts; Humans; Mice; Neovascularization, Pathologic; Platelet Endothelial Cell Adhesion Molecule-1; Psoriasis; Skin; T-Lymphocytes; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-1 | 2015 |